You are here

  • Home
  • Archive
  • Volume 97, Issue Suppl 1
  • An estimate of the financial cost for treatment with enoxaparin as part of the implementation of new clinical guidelines for the reduction of the risk of thrombosis and embolism during pregnancy and the puerperium

Article info

Article menu
Download PDFPDF
Abstract
Maternal Medicine Posters
An estimate of the financial cost for treatment with enoxaparin as part of the implementation of new clinical guidelines for the reduction of the risk of thrombosis and embolism during pregnancy and the puerperium

Authors

Citation

McCauley M, White J, McElhenny C
An estimate of the financial cost for treatment with enoxaparin as part of the implementation of new clinical guidelines for the reduction of the risk of thrombosis and embolism during pregnancy and the puerperium
Archives of Disease in Childhood - Fetal and Neonatal Edition 2012;97:A48.

Publication history

  • First published April 18, 2012.
Online issue publication 
March 22, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions